| Nathan Fisher | |
|
600 Clifty St Ste 2 Somerset KY 42503-1710 | |
| (606) 678-0026 | |
| (606) 678-0047 |
| Full Name | Nathan Fisher |
|---|---|
| Speciality | Counselor |
| Location | 600 Clifty St Ste 2, Somerset, Kentucky |
| Authorized Official Name and Position | Nathan Fisher (CLINICAL DIRECTOR/OWNER) |
| Authorized Official Contact | 6066780026 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Nathan Fisher 600 Clifty St Suite 2 Somerset KY 42503-1733 Ph: (606) 492-4023 | Nathan Fisher 600 Clifty St Ste 2 Somerset KY 42503-1710 Ph: (606) 678-0026 |
| NPI Number | 1215475561 |
|---|---|
| Provider Enumeration Date | 02/07/2017 |
| Last Update Date | 12/20/2018 |
| Medicare PECOS PAC ID | 3173872256 |
|---|---|
| Medicare Enrollment ID | O20180822003279 |
News Archive
Intellectual Property Watch reports on discussions at the ongoing WHO Executive Board meeting "over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development [R&D] for neglected diseases predominantly afflicting poor populations."
In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.
An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
Meda has established an affiliate in Hong Kong. At the end of last year, Meda opened its China affiliate based in Beijing. Meda will begin by commercializing two of its well-established products in Hong Kong; Elidel for the treatment of atopic dermatitis (eczema) and azelastine for the treatment of allergic rhinitis.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215475561 | NPI | - | NPPES |
| 1215475561 | Other | KY | NPI (QUEST COUNSELING) |
| 7100395100 | Medicaid | KY | |
| 1881978807 | Other | KY | NPI (NATHAN FISHER) |
| 710044820 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 166819 (Kentucky) | Primary |
| Provider Name | Misty R Goldson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528069531 PECOS PAC ID: 4688640360 Enrollment ID: I20070809000660 |
News Archive
Intellectual Property Watch reports on discussions at the ongoing WHO Executive Board meeting "over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development [R&D] for neglected diseases predominantly afflicting poor populations."
In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.
An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
Meda has established an affiliate in Hong Kong. At the end of last year, Meda opened its China affiliate based in Beijing. Meda will begin by commercializing two of its well-established products in Hong Kong; Elidel for the treatment of atopic dermatitis (eczema) and azelastine for the treatment of allergic rhinitis.
› Verified 1 days ago
| Provider Name | Kelli N Jordan |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1710380035 PECOS PAC ID: 7810268711 Enrollment ID: I20170811000708 |
News Archive
Intellectual Property Watch reports on discussions at the ongoing WHO Executive Board meeting "over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development [R&D] for neglected diseases predominantly afflicting poor populations."
In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.
An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
Meda has established an affiliate in Hong Kong. At the end of last year, Meda opened its China affiliate based in Beijing. Meda will begin by commercializing two of its well-established products in Hong Kong; Elidel for the treatment of atopic dermatitis (eczema) and azelastine for the treatment of allergic rhinitis.
› Verified 1 days ago
| Provider Name | Natasha Larae Slaughter |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1659943033 PECOS PAC ID: 8527466333 Enrollment ID: I20211008001489 |
News Archive
Intellectual Property Watch reports on discussions at the ongoing WHO Executive Board meeting "over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development [R&D] for neglected diseases predominantly afflicting poor populations."
In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.
An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
Meda has established an affiliate in Hong Kong. At the end of last year, Meda opened its China affiliate based in Beijing. Meda will begin by commercializing two of its well-established products in Hong Kong; Elidel for the treatment of atopic dermatitis (eczema) and azelastine for the treatment of allergic rhinitis.
› Verified 1 days ago
| Provider Name | Heather Laurel Lawhorn |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1952025322 PECOS PAC ID: 2062880156 Enrollment ID: I20221121002724 |
News Archive
Intellectual Property Watch reports on discussions at the ongoing WHO Executive Board meeting "over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development [R&D] for neglected diseases predominantly afflicting poor populations."
In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.
An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
Meda has established an affiliate in Hong Kong. At the end of last year, Meda opened its China affiliate based in Beijing. Meda will begin by commercializing two of its well-established products in Hong Kong; Elidel for the treatment of atopic dermatitis (eczema) and azelastine for the treatment of allergic rhinitis.
› Verified 1 days ago
| Provider Name | Deanna Phillips |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1215634902 PECOS PAC ID: 8224402656 Enrollment ID: I20230324002145 |
News Archive
Intellectual Property Watch reports on discussions at the ongoing WHO Executive Board meeting "over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development [R&D] for neglected diseases predominantly afflicting poor populations."
In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.
An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
Meda has established an affiliate in Hong Kong. At the end of last year, Meda opened its China affiliate based in Beijing. Meda will begin by commercializing two of its well-established products in Hong Kong; Elidel for the treatment of atopic dermatitis (eczema) and azelastine for the treatment of allergic rhinitis.
› Verified 1 days ago
| Provider Name | James Michael Estes |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1659843407 PECOS PAC ID: 3779940341 Enrollment ID: I20230613002341 |
News Archive
Intellectual Property Watch reports on discussions at the ongoing WHO Executive Board meeting "over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development [R&D] for neglected diseases predominantly afflicting poor populations."
In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.
An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
Meda has established an affiliate in Hong Kong. At the end of last year, Meda opened its China affiliate based in Beijing. Meda will begin by commercializing two of its well-established products in Hong Kong; Elidel for the treatment of atopic dermatitis (eczema) and azelastine for the treatment of allergic rhinitis.
› Verified 1 days ago
| Provider Name | Miranda Perry |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1316635394 PECOS PAC ID: 6901266923 Enrollment ID: I20230721000765 |
News Archive
Intellectual Property Watch reports on discussions at the ongoing WHO Executive Board meeting "over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development [R&D] for neglected diseases predominantly afflicting poor populations."
In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.
An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
Meda has established an affiliate in Hong Kong. At the end of last year, Meda opened its China affiliate based in Beijing. Meda will begin by commercializing two of its well-established products in Hong Kong; Elidel for the treatment of atopic dermatitis (eczema) and azelastine for the treatment of allergic rhinitis.
› Verified 1 days ago
| Provider Name | Kari Elise Mccormick |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1154917227 PECOS PAC ID: 2961852272 Enrollment ID: I20231228003805 |
News Archive
Intellectual Property Watch reports on discussions at the ongoing WHO Executive Board meeting "over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development [R&D] for neglected diseases predominantly afflicting poor populations."
In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.
An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
Meda has established an affiliate in Hong Kong. At the end of last year, Meda opened its China affiliate based in Beijing. Meda will begin by commercializing two of its well-established products in Hong Kong; Elidel for the treatment of atopic dermatitis (eczema) and azelastine for the treatment of allergic rhinitis.
› Verified 1 days ago
| Provider Name | Tiffany Roberts |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1407531130 PECOS PAC ID: 7517318165 Enrollment ID: I20240108004011 |
News Archive
Intellectual Property Watch reports on discussions at the ongoing WHO Executive Board meeting "over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development [R&D] for neglected diseases predominantly afflicting poor populations."
In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.
An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
Meda has established an affiliate in Hong Kong. At the end of last year, Meda opened its China affiliate based in Beijing. Meda will begin by commercializing two of its well-established products in Hong Kong; Elidel for the treatment of atopic dermatitis (eczema) and azelastine for the treatment of allergic rhinitis.
› Verified 1 days ago
| Provider Name | Elizabeth Godsey |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1104283803 PECOS PAC ID: 8325499833 Enrollment ID: I20240109003800 |
News Archive
Intellectual Property Watch reports on discussions at the ongoing WHO Executive Board meeting "over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development [R&D] for neglected diseases predominantly afflicting poor populations."
In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.
An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
Meda has established an affiliate in Hong Kong. At the end of last year, Meda opened its China affiliate based in Beijing. Meda will begin by commercializing two of its well-established products in Hong Kong; Elidel for the treatment of atopic dermatitis (eczema) and azelastine for the treatment of allergic rhinitis.
› Verified 1 days ago
| Provider Name | Aaron Bruce Atwood |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1508214677 PECOS PAC ID: 0244682532 Enrollment ID: I20240123001708 |
News Archive
Intellectual Property Watch reports on discussions at the ongoing WHO Executive Board meeting "over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development [R&D] for neglected diseases predominantly afflicting poor populations."
In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.
An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
Meda has established an affiliate in Hong Kong. At the end of last year, Meda opened its China affiliate based in Beijing. Meda will begin by commercializing two of its well-established products in Hong Kong; Elidel for the treatment of atopic dermatitis (eczema) and azelastine for the treatment of allergic rhinitis.
› Verified 1 days ago
| Provider Name | Jada Gilmore Fisher |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1518406511 PECOS PAC ID: 5698127983 Enrollment ID: I20240123001747 |
News Archive
Intellectual Property Watch reports on discussions at the ongoing WHO Executive Board meeting "over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development [R&D] for neglected diseases predominantly afflicting poor populations."
In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.
An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
Meda has established an affiliate in Hong Kong. At the end of last year, Meda opened its China affiliate based in Beijing. Meda will begin by commercializing two of its well-established products in Hong Kong; Elidel for the treatment of atopic dermatitis (eczema) and azelastine for the treatment of allergic rhinitis.
› Verified 1 days ago
| Provider Name | Amy Renee Oliver |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700647955 PECOS PAC ID: 0345684411 Enrollment ID: I20240216000352 |
News Archive
Intellectual Property Watch reports on discussions at the ongoing WHO Executive Board meeting "over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development [R&D] for neglected diseases predominantly afflicting poor populations."
In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.
An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
Meda has established an affiliate in Hong Kong. At the end of last year, Meda opened its China affiliate based in Beijing. Meda will begin by commercializing two of its well-established products in Hong Kong; Elidel for the treatment of atopic dermatitis (eczema) and azelastine for the treatment of allergic rhinitis.
› Verified 1 days ago
News Archive
Intellectual Property Watch reports on discussions at the ongoing WHO Executive Board meeting "over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development [R&D] for neglected diseases predominantly afflicting poor populations."
In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.
An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
Meda has established an affiliate in Hong Kong. At the end of last year, Meda opened its China affiliate based in Beijing. Meda will begin by commercializing two of its well-established products in Hong Kong; Elidel for the treatment of atopic dermatitis (eczema) and azelastine for the treatment of allergic rhinitis.
› Verified 1 days ago
Hope Mental Health Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 411 Crab Orchard Rd, Somerset, KY 42503 Phone: 606-485-4673 Fax: 606-485-4600 | |
All In Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 402 Coomer St Ste 201, Somerset, KY 42503 Phone: 606-425-9112 | |
Ethas Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 149 Enterprise Dr, Somerset, KY 42501 Phone: 606-679-6995 Fax: 606-451-9465 | |
Wellsprings Wellness Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 200 Belmont Ave, Somerset, KY 42501 Phone: 606-687-2038 Fax: 606-200-3654 | |
Susan J. Miller, Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 110 Richie Ln, Suite C, Somerset, KY 42503 Phone: 606-305-3791 Fax: 606-678-0603 | |
Catalyst Management Incorporated Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 321 Ringgold Rd, Somerset, KY 42503 Phone: 606-679-9009 Fax: 606-678-9883 | |
Zev Zusman Md Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 310 Langdon St Ste 5, Somerset, KY 42503 Phone: 606-678-7664 Fax: 606-678-9139 |